Patent EP0233770A2 successfully refreshed from Google Patents.
EP0233770A2
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Collagen compositions for bone repair containing autogeneic marrow
Assignee: Ramot at Tel Aviv University Ltd
•
Filing: 1987-02-16
•
Granted: —
•
Expires: 2007-02-16
Abstract
Abstract composition which combines autogenic bone marrow with a suspension of purified atelopeptide reconstituted collagen is used to repair bone defects in mammals.
Inventors
- 👤 Karl A. Piez
- 👤 Shlomo Weintraub
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-10-31 19:53
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/36; A61L27/3604; A61L27/3608; A61F; A61F2/00; A61F2/02; A61F2/28; A61K; A61K35/00; A61K35/12; A61K35/28; A61L27/14; A61L27/22; A61L27/24; A61L27/3641; A61L27/3645; A61L27/365; Y; Y10; Y10S; Y10S128/00; Y10S128/08
Claims Analysis
Total Claims: 15
Claim 1
Independent Claim
10 words
A composition comprising reconstituted fibrillar purified collagen and bone marrow.
Claim 2
Dependent Claim
10 words
A composition comprising reconstituted fibrillar purified collagen and bone marrow.
Claim 3
Dependent Claim
20 words
A composition comprising reconstituted fibrillar atelopeptide purified collagen and bone marrow for use in the repair of a bone defect.
Claim 4
Dependent Claim
20 words
A composition comprising reconstituted fibrillar atelopeptide purified collagen and bone marrow for use in the repair of a bone defect.
Claim 5
Dependent Claim
30 words
A composition according to claim 1 or 2 in which the composition comprises an aqueous suspension comprising 10 to 100 mg/ml of collagen and an aqueous suspension of bone marrow.
Claim 6
Dependent Claim
20 words
A composition as claimed in claim 3 wherein the collagen suspension comprises 50% to 95% by volume of the composition.
Claim 7
Dependent Claim
17 words
A composition as claimed in claim 3 or 4 in which the composition is an injectable suspension.
Claim 8
Dependent Claim
28 words
A process for the preparation of a composition as claimed in any one of claims 1 to 5 comprising mixing reconstituted fibrillar atelopeptide purified collagen and bone marrow.
Claim 9
Dependent Claim
22 words
A process according to claim 6 in which an aqueous suspension of collagen is mixed with an aqueous suspension of bone marrow.
Claim 10
Dependent Claim
27 words
Collagen for use in the manufacture of a composition comprising reconstituted fibrillar atelopeptide purified collagen and bone marrow for use in the repair of a bone defect.
Claim 11
Dependent Claim
27 words
Collagen for use in the manufacture of a composition comprising reconstituted fibrillar atelopeptide purified collagen and bone marrow for use in the repair of a bone defect.
Claim 12
Dependent Claim
27 words
Use of collagen in the manufacture of a composition comprising reconstituted fribrillar atelopeptide purified collagen and bone marrow for use in the repair of a bone defect.
Claim 13
Dependent Claim
27 words
Use of collagen in the manufacture of a composition comprising reconstituted fribrillar atelopeptide purified collagen and bone marrow for use in the repair of a bone defect.
Claim 14
Dependent Claim
29 words
A cosmetic method for treatment of the human or animal body comprising the step of repairing a bone defect using reconstituted fribrillar atelopeptide purifed collagen and autogeneic bone marrow.
Claim 15
Dependent Claim
29 words
A cosmetic method for treatment of the human or animal body comprising the step of repairing a bone defect using reconstituted fribrillar atelopeptide purifed collagen and autogeneic bone marrow.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.